The largest database of trusted experimental protocols

8 protocols using anti cd56 apc

1

Flow Cytometric Characterization of nDCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purity and phenotype of nDCs after immunomagnetic isolation were determined by flow cytometry with a FACSVerse® (BD biosciences, San Jose, CA) or MACS Quant® (Miltenyi Biotec). For this purpose, the following primary monoclonal antibodies and the appropriate isotype or fluorescence minus one controls were used: anti-CD1c-Viobright-FITC, anti-BDCA2-PE, anti-CD123-APC, anti-CD20-PE-Vio770, anti-CD45-APC-Vio770, anti-CD14-Viogreen, anti-FcεRI-BioBlue, anti-CD14-FITC, anti-CD15-PE, anti-CD56-APC, anti-CD3-VioBlue, anti-HLA-ABC-APC, anti-HLA-DR/DP/DQ-APC, anti-CCR7-APC, anti-CD80-APC, anti-CD83-APC, and anti-CD86-APC (all Miltenyi Biotec). Details are depicted in Supplementary Table 2. The purity of the nDC product was defined as the percentage of nDCs (sum of CD123+BDCA2+ pDC plus CD1c+CD20- cDC2) of all viable cells in the nDC product. After 6 h of protamine/mRNA stimulation, cytokine production of nDCs was measured in the supernatant by cytometric bead array according to the manufacturer’s instruction (Miltenyi Biotec).
+ Open protocol
+ Expand
2

Cryopreservation and Functionality of CB-NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CB-NK cells were cryopreserved using a freezing medium consisting of 50% Plasmalyte (Baxter International Inc.), 40% human AB serum and 10% DMSO (Thermo Scientific) at 2x106 cells per ml per vial. NK cells were thawed in a bath at 37°C, centrifuged at 362g for 5 minutes and resuspended in “NK medium”. The next day, cells’ viability was checked by flow cytometry. In order to test their functionality, thawed CB-NK cells were co-cultured with K562 target cells at a ratio of 1:1 in a 24-well plate for 4 h at 37°C. At the beginning of the assay, anti-CD107a-BV421 (BD Biosciences, clone H4A3) was added in order to detect the degranulation activity of the effector cells against the target cells. Golgi Stop (BD Biosciences) (monensin) was added following the manufacturer’s protocol. After the incubation, cells were collected, washed, and labeled with anti-CD3-PerCP/Cy5.5 (Biolegend, clone SK7), anti-CD56-APC (Miltenyi Biotec, clone REA196) and analyzed using flow cytometry. Degranulating NK cells, characterized by the expression of CD107a were determined in the CD56+/CD3− cell population.
+ Open protocol
+ Expand
3

NK Cell-Mediated CD4 T Cell Cytotoxicity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Uninfected CD4 T cells were isolated as above and treated or not with HDACi at the indicated doses. Meanwhile NK cells were isolated as above. NK and CD4 T cells were cultured at a 1:1, 1:0.2, or 1:0.01 ratio for 5 hours at 37°C in the presence of an anti-CD107a PE-Cy7 antibody (Biolegend). Experiments using K562 cells were performed at a 1:1 ratio for 5 hours as with CD4 T cells. For both CD4 T and K562 experiments, cells were then washed and stained with a panel of: LIVE/DEAD fixable near-IR dead cell stain kit (Life Technologies), anti-CD3 eflour450 (eBioscience), anti-CD56 APC (Miltenyi), anti-CD16 FITC (Biolegend), anti-CD14 APC-Cy7 (Biolegend), anti-CD19 APC Cy7 (Biolegend). NK cells were gated on APC Cy7 negative cells (live, CD14-, CD19-), CD3 negative, CD56 positive cells.
+ Open protocol
+ Expand
4

Flow Cytometric Characterization of Gene-Modified NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CAR and CD16 expression on gene-modified NK cells as well as the possible contamination with CD3-positive cells were analyzed every 3–7 days post transduction using flow cytometry. For NK and CAR-NK cell phenotyping, fluorochrome-conjugated antibodies anti-KIR2D-VioBlue (clone REA1042), anti-CD16-VioGreen (clone REA423), anti-NKG2C-PE (clone REA205), anti-NKG2A-PE-Vio770 (clone REA110), anti-CD57-APC-Vio770 (clone REA769), anti-CD56-APC (clone REA 196), anti-NKp44-PE (clone REA1163), anti-NKp30-PE-Vio770 (clone REA823), anti-CD33-VioBright515 (clone REA775) (all Miltenyi Biotec), anti-DNAM-1-BV421 (clone 11A8), anti-NKG2D-BV510 (clone 1D11), anti-CD56-BV786 (clone NCAM16.2), anti-CD16-PE-CF594 (clone 3G8), anti-CD3-BUV395 (clone Sk7) (all BD Biosciences) were used. CD33-CAR expression was analyzed with a CD33-CAR Detection Reagent, containing a recombinantly expressed fusion protein consisting of the human CD33 extracellular domains and a specifically mutated human IgG1 Fc region (Miltenyi Biotec) and secondary addition of anti-biotin-PE antibody (clone REA746) (Miltenyi Biotec).
+ Open protocol
+ Expand
5

Flow Cytometric Characterization of NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-CD14-PerCP (BD Pharmingen, USA), anti-CD3-PE (Dako, USA), and anti-CD56-APC (Miltenyi Biotec) were used for the analysis of purity of isolated NK cells. Samples were analyzed by flow cytometry (FACSCalibur, BD Biosciences, USA). The flow cytometry data were analyzed using FlowJo software version 7.6 (TreeStar, Ashland, OR, USA) and Flowing Software version 2.0 (Dr. Perttu Terho, Finland).
+ Open protocol
+ Expand
6

Isolation and Characterization of Human NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The use of human PBMCs, including NK cells from healthy donors, was approved by the local ethical committee (#EK242102007) of the Medical Faculty Carl Gustav Carus, Technische Universitat Dresden. After obtaining oral and written consent, PBMCs were isolated by Biocoll gradient centrifugation (Biochrom, Berlin, Germany) and human cytomegalovirus (HCMV) IgG and IgM titers were analyzed using ELISA. Untouched NK cells were prepared using the negative NK Cell Isolation Kit (Miltenyi Biotec). Staining with anti-CD56-APC, anti-CD3-FITC and anti-CD19-PE antibodies (Miltenyi Biotec) routinely confirmed 90% purity of CD56 + NK cells and depletion of CD3 + T cells and CD19 + B cells. B cells were isolated from PBMCs using the negative Pan B Cell Isolation Kit (Miltenyi Biotec). PBMCs and NK cells were held at 37°C and 5% CO 2 in a humidified incubator.
+ Open protocol
+ Expand
7

Phenotypic Characterization of Isolated mDCs and pDCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purity and phenotype of mDCs and pDCs after CliniMACS isolation were determined by flow cytometry with a FACSVerse (BD Biosciences, San Jose, CA, USA) or MACS Quant (Miltenyi Biotec). The following primary monoclonal antibodies and the appropriate isotype or fluorescence minus one controls were used: anti-CD1c-Viobright FITC, anti-BDCA-2-PE, anti-CD20-PE-Vio770, anti-CD123-APC, anti-CD45-APC-Vio770, anti-CD14-VioGreen, anti-FcεRI-VioBlue, anti-CD14-FITC, anti-CD15-PE, anti-CD56-APC, anti-CD3-BioBlue, anti-HLA-ABC-APC, anti-HLA-DR,DP,DQ-APC, anti-CCR7-APC, anti-CD80-APC, anti-CD83-APC and anti-CD86-APC (all Miltenyi Biotec).
+ Open protocol
+ Expand
8

Apoptosis and Cell Cycle Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Apoptosis was analysed using annexin V-fluorescein isothiocyanate (FITC) and propidium iodide (PI) as previously described [17] . Briefly, following treatment cells were washed with annexin V binding buffer (5 mM HEPES, 70 mM NaCl, 1.25 mM CaCl 2 pH 7.4) and stained with annexin V-FITC (iQ Corporation, Groningen, The Netherlands). Following washing with annexin V binding buffer, cells were resuspended in PI (0.5 μg/mL) in binding buffer and analysed on either a BD Accuri C6 or BD FACS Canto II flow cytometers (BD Sciences) using FloJo software (Ashland, Oregon, United States).
To determine the cytotoxic effects of VP79s in lymphocytes, 1 × 10 5 normal donor PBMCs per well were treated as indicated and stained with anti-CD56-APC (NK cells), anti-CD19-PE (B cells) and anti-CD3-PerCP (T cells) antibodies (Miltenyi Biotec, Bergisch Gladbach, Germany) as per manufacturer's protocol. Samples were analysed by flow cytometry on the BD FACS Canto II flow cytometer with cell viability determined by DAPI exclusion (Pacific blue).
Cell cycle was analysed by DNA quantification following staining by propidium iodide (PI). After treatment, NCI-H929 and U266B1 cells were fixed in 70% ethanol and incubated with 10 μg/mL of RNase A (Sigma-Aldrich) and 100 μg/mL PI (Sigma-Aldrich). Analysis was performed using a BD Accuri C6 flow cytometer and software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!